Sensei Biotherapeutics to Participate in the Piper Sandler 34th Annual Healthcare Conference
BOSTON, Nov. 22, 2022 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, President and Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference, being held in New York, NY, on Thursday, December 1, 2022, at 2:00 p.m. ET.
Related news for (SNSE)
- Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
- Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress
- Breaking News: MoBot’s Latest Update as of 03/28/25 10:00 AM
- Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress
- Today’s Top Performers: MoBot’s Market Review 03/28/25 09:00 AM